- $5.96bn
- $6.26bn
- $739.02m
- 48
- 21
- 83
- 49
Annual balance sheet for Guardant Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,795 | 933 | 1,011 | 1,169 | 840 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 53.3 | 97.7 | 97.3 | 88.8 | 110 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1,888 | 1,114 | 1,192 | 1,347 | 1,055 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 100 | 314 | 342 | 303 | 279 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,272 | 2,204 | 1,610 | 1,786 | 1,486 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 66.8 | 195 | 193 | 206 | 226 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 973 | 1,559 | 1,550 | 1,628 | 1,625 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | 1,298 | 645 | 60.2 | 159 | -140 |
Total Liabilities & Shareholders' Equity | 2,272 | 2,204 | 1,610 | 1,786 | 1,486 |
Total Common Shares Outstanding |